Bonnie L. Svarstad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bonnie L. Svarstad has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Jeanine K. Mount
8 shared publicationsTheresa I. Shireman
3 shared publicationsCecilia Claesson
2 shared publicationsDara C. Bultman
2 shared publicationsEllen R. Tabak
2 shared publicationsEva M. Vivian
2 shared publications
Latest Publications
- 1 September 2013
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 53 (5) , 520-529
Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial
- 1 September 2013
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 53 (5) , 520-529
Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial
- 1 May 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 2 (3) , 264-271
The Team Education and Adherence Monitoring (TEAM) Trial
Recent studies suggest that involving pharmacists is an effective strategy for improving patient adherence and blood pressure (BP) control. To date, few controlled studies have tested the cost-effectiveness of specific models for improving patient adherence and BP control in community pharmacies, where most Americans obtain prescriptions. We hypothesized that a team model of adherence monitoring and intervention in corporately owned community pharmacies can improve patient adherence, prescribing, and BP control among hypertensive black patients. The Team Education and Adherence Monitoring (TEAM) Trial is a randomized controlled trial testing a multistep intervention for improving adherence monitoring and intervention in 28 corporately owned community pharmacies. Patients in the 14 control pharmacies received “usual care,” and patients in the 14 intervention pharmacies received TEAM Care by trained pharmacists and pharmacy technicians working with patients and physicians. Data collectors screened 1250 patients and enrolled 597 hypertensive black patients. The primary end points were the proportion of patients achieving BP control and reductions in systolic and diastolic BP measured after 6 and 12 months. Secondary end points were changes in adherence monitoring and intervention, patient adherence and barriers to adherence, prescribing, and cost-effectiveness. Researchers also will examine potential covariates and barriers to change. Involving pharmacists is a potentially powerful means of improving BP control in blacks. Pharmacists are in an excellent position to monitor patients between clinic visits and to provide useful information to patients and physicians.
- 1 May 2009
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 2 (3) , 264-271
The Team Education and Adherence Monitoring (TEAM) Trial
Recent studies suggest that involving pharmacists is an effective strategy for improving patient adherence and blood pressure (BP) control. To date, few controlled studies have tested the cost-effectiveness of specific models for improving patient adherence and BP control in community pharmacies, where most Americans obtain prescriptions. We hypothesized that a team model of adherence monitoring and intervention in corporately owned community pharmacies can improve patient adherence, prescribing, and BP control among hypertensive black patients. The Team Education and Adherence Monitoring (TEAM) Trial is a randomized controlled trial testing a multistep intervention for improving adherence monitoring and intervention in 28 corporately owned community pharmacies. Patients in the 14 control pharmacies received “usual care,” and patients in the 14 intervention pharmacies received TEAM Care by trained pharmacists and pharmacy technicians working with patients and physicians. Data collectors screened 1250 patients and enrolled 597 hypertensive black patients. The primary end points were the proportion of patients achieving BP control and reductions in systolic and diastolic BP measured after 6 and 12 months. Secondary end points were changes in adherence monitoring and intervention, patient adherence and barriers to adherence, prescribing, and cost-effectiveness. Researchers also will examine potential covariates and barriers to change. Involving pharmacists is a potentially powerful means of improving BP control in blacks. Pharmacists are in an excellent position to monitor patients between clinic visits and to provide useful information to patients and physicians.
- 1 July 2005
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 45 (4) , 443-451
Expert and Consumer Evaluation of Patient Medication Leaflets Provided in U.S. Pharmacies
- 1 July 2005
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 45 (4) , 443-451
Expert and Consumer Evaluation of Patient Medication Leaflets Provided in U.S. Pharmacies
- 1 March 2005
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 45 (2) , 127-129
Measuring Adherence in Community Pharmacies: Opportunities and Challenges
- 1 March 2005
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 45 (2) , 127-129
Measuring Adherence in Community Pharmacies: Opportunities and Challenges
- 1 September 2004
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 68 (3)
The Status of Women in Pharmacy Education: Persisting Gaps and Issues
- 1 September 2004
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 68 (3)
The Status of Women in Pharmacy Education: Persisting Gaps and Issues
- 1 January 2004
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 44 (1) , 22-29
Patient Counseling Provided in Community Pharmacies: Effects of State Regulation, Pharmacist Age, and Busyness
- 1 January 2004
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 44 (1) , 22-29
Patient Counseling Provided in Community Pharmacies: Effects of State Regulation, Pharmacist Age, and Busyness
- 1 May 2003
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 43 (3) , 383-393
Evaluation of Written Prescription Information Provided in Community Pharmacies: A Study in Eight States
- 1 May 2003
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 43 (3) , 383-393
Evaluation of Written Prescription Information Provided in Community Pharmacies: A Study in Eight States
- 1 September 2002
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 53 (9) , 1159-1165
Effects of Residents' Depression, Sleep, and Demand for Medication on Benzodiazepine Use in Nursing Homes
This study sought to identify risk factors associated with the prescription and use of benzodiazepines in nursing homes and to assess the prevalence and determinants of demand for benzodiazepines among nursing home residents. Data were available for 2,060 residents who had participated in a previous study of use of medications in 18 randomly selected nursing homes in Wisconsin between 1986 and 1989. Data sources included nursing home and pharmacy records; nurses' assessments of residents' behavior, pain, sleep, and demand for medication; and researchers' observations of resident requests for medication. Measures of benzodiazepine use included benzodiazepine prescriptions, prevalence and extent of as-needed drug use, and chronic use as defined by Health Care Financing Administration guidelines. A quarter of the residents received prescriptions for benzodiazepines. Of these, 71 percent received prescriptions to aid sleep or to be taken at bedtime; 32 percent used benzodiazepines for a longer period than recommended; and 26 percent requested medication. Logistic regression analysis showed that residents with depression, pain, or sleep problems were more likely to have received benzodiazepines and to have requested medication. Chronic use was significantly higher among residents with depression, sleep problems, or multiple benzodiazepine regimens and among those who requested medication. Demand and sleep problems also were associated with higher rates of any as-needed use and with higher numbers of as-needed doses used. Efforts to improve benzodiazepine use in nursing homes must address the need for better assessment and management of depression, sleep, pain, and residents' demand for these medications.
- 1 September 2002
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 53 (9) , 1159-1165
Effects of Residents' Depression, Sleep, and Demand for Medication on Benzodiazepine Use in Nursing Homes
This study sought to identify risk factors associated with the prescription and use of benzodiazepines in nursing homes and to assess the prevalence and determinants of demand for benzodiazepines among nursing home residents. Data were available for 2,060 residents who had participated in a previous study of use of medications in 18 randomly selected nursing homes in Wisconsin between 1986 and 1989. Data sources included nursing home and pharmacy records; nurses' assessments of residents' behavior, pain, sleep, and demand for medication; and researchers' observations of resident requests for medication. Measures of benzodiazepine use included benzodiazepine prescriptions, prevalence and extent of as-needed drug use, and chronic use as defined by Health Care Financing Administration guidelines. A quarter of the residents received prescriptions for benzodiazepines. Of these, 71 percent received prescriptions to aid sleep or to be taken at bedtime; 32 percent used benzodiazepines for a longer period than recommended; and 26 percent requested medication. Logistic regression analysis showed that residents with depression, pain, or sleep problems were more likely to have received benzodiazepines and to have requested medication. Chronic use was significantly higher among residents with depression, sleep problems, or multiple benzodiazepine regimens and among those who requested medication. Demand and sleep problems also were associated with higher rates of any as-needed use and with higher numbers of as-needed doses used. Efforts to improve benzodiazepine use in nursing homes must address the need for better assessment and management of depression, sleep, pain, and residents' demand for these medications.
- 1 December 2001
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 49 (12) , 1673-1678
Chronic Benzodiazepine Use in Nursing Homes: Effects of Federal Guidelines, Resident Mix, and Nurse Staffing
To assess the overall prescribing and chronic use of benzodiazepines (BZs) in nursing homes before and after implementation of BZ guidelines by the Health Care Finance Administration (HCFA). A second aim was to identify facility predictors of BZ prescribing and chronic use after guideline implementation. Nonexperimental, observational study design. Drug use was assessed in 16 randomly selected skilled nursing facilities in Wisconsin before 1990 and again in 1993-1994. One thousand one hundred eighty-one Medicaid-funded residents at baseline and 1,650 Medicaid-funded residents at follow-up. Drug use measures included percentage of residents with prescribed BZs and percentage of residents with chronic BZ use (defined as >or=4 months of continuous use). A 4-month cutoff was used because HCFA guidelines consider this length of continuous use to be potentially excessive. Facility predictors of drug use included resident demographic and diagnostic mix, size, ownership, Medicaid per diem, and nurse staffing. Before 1990, one-fourth of all residents were prescribed a BZ and nearly one-tenth of all residents had chronic BZ use. Federal guidelines had nonsignificant effects on these measures; BZ prescribing declined only 3.6% (26.4-22.8%) and chronic use declined only 1.3% (9.2-7.9%). Regression results showed that overall prescribing at follow-up was higher in facilities with more female residents (beta= .52, P= .018) and residents with psychiatric disorders (beta= .41, P= .045). However, nurse staffing was the only significant predictor of chronic BZ use. As expected, better nurse staffing was associated with lower rates of chronic use (beta= -0.46, P= .037). Efforts to improve BZ use in nursing homes must address the need for better nurse staffing and better assessment and management of psychiatric disorders that can trigger BZ prescribing.
- 1 December 2001
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 49 (12) , 1673-1678
Chronic Benzodiazepine Use in Nursing Homes: Effects of Federal Guidelines, Resident Mix, and Nurse Staffing
To assess the overall prescribing and chronic use of benzodiazepines (BZs) in nursing homes before and after implementation of BZ guidelines by the Health Care Finance Administration (HCFA). A second aim was to identify facility predictors of BZ prescribing and chronic use after guideline implementation. Nonexperimental, observational study design. Drug use was assessed in 16 randomly selected skilled nursing facilities in Wisconsin before 1990 and again in 1993-1994. One thousand one hundred eighty-one Medicaid-funded residents at baseline and 1,650 Medicaid-funded residents at follow-up. Drug use measures included percentage of residents with prescribed BZs and percentage of residents with chronic BZ use (defined as >or=4 months of continuous use). A 4-month cutoff was used because HCFA guidelines consider this length of continuous use to be potentially excessive. Facility predictors of drug use included resident demographic and diagnostic mix, size, ownership, Medicaid per diem, and nurse staffing. Before 1990, one-fourth of all residents were prescribed a BZ and nearly one-tenth of all residents had chronic BZ use. Federal guidelines had nonsignificant effects on these measures; BZ prescribing declined only 3.6% (26.4-22.8%) and chronic use declined only 1.3% (9.2-7.9%). Regression results showed that overall prescribing at follow-up was higher in facilities with more female residents (beta= .52, P= .018) and residents with psychiatric disorders (beta= .41, P= .045). However, nurse staffing was the only significant predictor of chronic BZ use. As expected, better nurse staffing was associated with lower rates of chronic use (beta= -0.46, P= .037). Efforts to improve BZ use in nursing homes must address the need for better nurse staffing and better assessment and management of psychiatric disorders that can trigger BZ prescribing.
- 1 June 2001
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 52 (6) , 805-811
Using Drug Claims Data to Assess the Relationship of Medication Adherence With Hospitalization and Costs
OBJECTIVE: This naturalistic study used claims data to examine the relationship of medication nonadherence to hospital use and costs among severely mentally ill clients in Wisconsin. METHODS: Data ...
- 1 June 2001
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 52 (6) , 805-811
Using Drug Claims Data to Assess the Relationship of Medication Adherence With Hospitalization and Costs
OBJECTIVE: This naturalistic study used claims data to examine the relationship of medication nonadherence to hospital use and costs among severely mentally ill clients in Wisconsin. METHODS: Data ...